Recruiting PHASE1/PHASE2 INTERVENTIONAL 1-arm
NCT07432633
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
A Phase 1/2 Study of [18F]FPyQCP for PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Sponsor: Blue Earth Diagnostics
Conditions
Colorectal Cancer Epithelial Ovarian Cancer Gastric Cancer Invasive Lobular Breast Carcinoma Pancreatic Ductal Adenocarcinoma
Interventions
[18F]FPyQCP
Updated 1 time since 2026 Last updated: Feb 19, 2026 Started: Jan 31, 2026 Primary completion: Jan 31, 2028 Completion: Jan 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1/PHASE2 clinical study on Colorectal Cancer and Epithelial Ovarian Cancer, this trial is actively recruiting participants. The trial is conducted by Blue Earth Diagnostics and has accumulated 1 data snapshot since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Recruiting — PHASE1/PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Blue Earth Diagnostics
- Medpace, Inc.
Data source: Blue Earth Diagnostics
For direct contact, visit the study record on ClinicalTrials.gov .